DuPont Nutrition & Health (N&H) has announced that it will divest its alginates business to Germany-based functional ingredients firm JRS Group, after the deal was approved by the European Commission (EC).
This sale was a requirement established by the EC following DuPont’s acquisition of FMC’s Health and Nutrition (H&N) business in 2017.
The sale includes the heritage DuPont N&H Alginates business, the portfolio of pectin-alginate blends, the business’s Landerneau production facility and the company’s customers.
DuPont says that the transaction is expected to close in Q3 2018, and it will continue to operate in the alginates market through the FMC H&N alginates portfolio.
Matthias Heinzel, DuPont N&H business president said: “The receipt of regulatory approval to divest the heritage DuPont N&H Alginates business is an important step in finalizing our integration of FMC’s Health & Nutrition Business.
“Our team is dedicated to creating value for our customers through the integration of our new DuPont N&H product portfolio, which combines the heritage portfolios of DuPont N&H, FMC H&N and Dow Food & Pharma to deliver a unique offering in the food ingredients and pharma excipients market.”
Josef Otto Rettenmaier, President of JRS Group added: “The receipt of regulatory approval from the EU Commission to acquire DuPont’s Alginate business is another milestone in strengthening the Life Science Division of JRS Group.
“We are continuously complementing our broad product portfolio to develop innovative solutions for our global customers. JRS focusses on ‘Green Products’ made of renewable, botanical resources. Therefore, alginates perfectly fit our product portfolio of excipients and hydrocolloids for pharma, food and personal care applications.
“We are fully committed to ensuring a seamless transition of the business and will be in contact with all customers prior to closing.”
© FoodBev Media Ltd 2024